Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Critical Care Clinics|June 21, 2012
The role of plasmapheresis in critical illnessTrung C Nguyen, Joseph E Kiss, Jordana R Goldman, et al.Transfusion|December 17, 2009
Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIICMark H Yazer, Darrell J Triulzi, Andrea Cortese Hassett, et al.Journal of Clinical Apheresis|August 9, 2020
Process mapping of the urgent red cell exchange procedure for patients with severe complications of sickle cell disease at a centralized hemapheresis serviceJacob A Smith, Jansen N Seheult, Joan Sevcik, et al.Journal of Clinical Apheresis|June 25, 2021
Benchmarking the centralized urgent plasma exchange service for patients admitted with a diagnosis of suspected acquired thrombotic thrombocytopenic purpura at a large healthcare systemJansen N Seheult, Michelle N Stram, Joan Sevcik, et al.Journal of Clinical Apheresis|October 15, 2013
Seasonal distribution of severe ADAMTS13 deficient idiopathic thrombotic thrombocytopenic purpuraJay S Raval, Sarah K Harm, Marian A Rollins-Raval, et al.Transfusion|June 26, 2023
How do we…consistently provide high-dose granulocyte products for transfusions in neutropenic patients?Robert Bubar, Joseph E Kiss, Darrell J Triulzi, et al.Journal of Clinical Apheresis|April 19, 2006
Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disordersJames N George, Robert D Woodson, Joseph E Kiss, et al.Annals of Hematology|September 11, 2024
Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpuraJennifer M Jones, Alesia Kaplan, Irina Chibisov, et al.Transfusion|May 26, 2017
Quantification of body iron and iron absorption in the REDS-II Donor Iron Status Evaluation (RISE) studyJoseph E Kiss, Rebecca J Birch, Whitney R Steele, et al.Cytotherapy|November 6, 2023
Predicting the CD34 content of mobilized peripheral blood leukapheresis products: single institution experience over 20 yearsYaşa G Mutlu, Joan Sevcik, Joseph E Kiss, et al.Pageof 7